|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.027 +0.003 (+12.500%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | (35,820) | (58,579) | (122,810) | (31,048) | (7,818) |
| Net Cash from / (used in) Investing Activities | 47,178 | 5,418 | 129,167 | (19,913) | 48,155 |
| Net Cash from / (used in) Financing Activities | (8,831) | (19,426) | 83,408 | (6,473) | (1,043) |
| Increase / (Decrease) in Cash & Cash Equivalents | 2,527 | (72,587) | 89,765 | (57,434) | 39,294 |
| Cash & Cash Equivalents at beginning of period | 173,450 | 259,264 | 176,600 | 230,176 | 194,765 |
| Effect of Foreign Exchange Rate Changes | (1,899) | (13,227) | (7,101) | 3,858 | (3,883) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 174,078 | 173,450 | 259,264 | 176,600 | 230,176 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -24,264,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.091 |